LAMP1 and systemic lupus erythematosus: Active SLE-patients had significantly increased percentages of CD107a+ cytotoxic T-cells as compared to inactive SLE-patients (49.8 ± 20.5% vs. 34.6 ± 15.1%, p = 0.02).